POSITRON EMISSION TOMOGRAPHY IMAGING IN ONCOLOGY
- 1 September 2001
- journal article
- review article
- Published by Elsevier BV in Radiologic Clinics of North America
- Vol. 39 (5), 883-917
- https://doi.org/10.1016/s0033-8389(05)70319-5
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- FDG-PET and CT in Evaluation of Chemotherapy in Advanced Head and Neck CancerClinical Positron Imaging, 2000
- The clinical utility of endoscopic ultrasound–guided fine-needle aspiration in the diagnosisand staging of pancreatic carcinomaGastrointestinal Endoscopy, 1997
- FDG-PET Evaluation of Indeterminate Pancreatic MassesJournal of Computer Assisted Tomography, 1996
- Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy?European Journal of Cancer, 1995
- Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imagingEuropean Journal of Surgical Oncology, 1995
- Fluorodeoxyglucose positron emission tomography in pancreatic cancer: an unsolved problemEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995
- Assessment of Primary and Metastatic Ovarian Cancer by Positron Emission Tomography (PET) Using 2-[18F]Deoxyglucose (2-[18F]FDG)Gynecologic Oncology, 1993
- Pancreatic cancer detected by positron emission tomography with 18F-labelled deoxyglucoseNuclear Medicine Communications, 1993
- Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancerCancer, 1993
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992